Position in NAGE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$406,253
-$65,830 QoQ
Shares Held
92,121
+24.1% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AVIVA PLC holds $267,602,543 across 25 Biotechnology names. NAGE ranks #20 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
222,452 | $99,333,716 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
91,176 | $70,446,224 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
114,003 | $37,720,172 | |
| 4 | INSM |
INSMED Inc
|
122,074 | $19,961,540 | |
| 5 | RPRX |
Royalty Pharma plc
|
323,823 | $15,533,789 | |
| 6 | INCY |
Incyte Corp
|
148,088 | $13,938,042 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
21,460 | $2,086,985 | |
| 8 | EXEL |
Exelixis, Inc.
|
25,153 | $1,078,812 |
All Filings in NAGE
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $406,253 | 92,121 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $472,083 | 74,227 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $464,643 | 49,801 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $563,301 | 39,091 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $366,079 | 53,055 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||